PositiveID Corp. (OTCQB: PSID) is an emerging company that develops biological detection and diagnostic systems for America’s homeland defense and the global healthcare market. PositiveID focuses on microfluidic systems for automated preparation and performance evaluations in order to detect biological threats and outbreaks whether airborne, in a healthcare facility, or at the point of need. The company’s systems, M-BAND and Firefly Dx, use real-time polymerase chain reaction (PCR) chemistry which diagnoses and identifies diseases, bacteria and viruses. Real-time PCR is one of the most sensitive bio-detection capabilities available today. For more information, visit the company’s website at www.positiveidcorp.com.